Literature DB >> 31451830

From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides.

Steffen Köcher1, Sarah Resch1, Till Kessenbrock1, Lukas Schrapp1, Michael Ehrmann2, Markus Kaiser1.   

Abstract

Covering: 1989 up to 2019 Ahp-cyclodepsipeptides (also known as Ahp-containing cyclodepsipeptides, cyanopeptolins, micropeptins, microginines, and lyngbyastatins, and by many other names) are a family of non-ribosomal peptide synthesis (NRPS)-derived natural products with potent serine protease inhibitory properties. Here, we review their isolation and structural elucidation from natural sources as well as studies of their biosynthesis, molecular mode of action, and use in drug discovery efforts. Accordingly, this summary aims to provide a comprehensive overview of the current state-of-the-art Ahp-cyclodepsipeptide research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31451830     DOI: 10.1039/c9np00033j

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  7 in total

1.  Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

Authors:  Lena Keller; Kirley Marques Canuto; Chenxi Liu; Brian M Suzuki; Jehad Almaliti; Asfandyar Sikandar; C Benjamin Naman; Evgenia Glukhov; Danmeng Luo; Brendan M Duggan; Hendrik Luesch; Jesko Koehnke; Anthony J O'Donoghue; William H Gerwick
Journal:  ACS Chem Biol       Date:  2020-01-28       Impact factor: 5.100

2.  Ahp-Cyclodepsipeptide Inhibitors of Elastase: Lyngbyastatin 7 Stability, Scalable Synthesis, and Focused Library Analysis.

Authors:  Danmeng Luo; Hendrik Luesch
Journal:  ACS Med Chem Lett       Date:  2020-03-04       Impact factor: 4.345

Review 3.  Targeting eukaryotic proteases for natural products-based drug development.

Authors:  Fatma H Al-Awadhi; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2020-06-24       Impact factor: 13.423

4.  Phosphate Limitation Increases Content of Protease Inhibitors in the Cyanobacterium Microcystis aeruginosa.

Authors:  Christian Burberg; Thomas Petzoldt; Eric von Elert
Journal:  Toxins (Basel)       Date:  2020-01-06       Impact factor: 4.546

5.  The Landscape of Recombination Events That Create Nonribosomal Peptide Diversity.

Authors:  Martin Baunach; Somak Chowdhury; Pierre Stallforth; Elke Dittmann
Journal:  Mol Biol Evol       Date:  2021-05-04       Impact factor: 16.240

6.  Native metabolomics identifies the rivulariapeptolide family of protease inhibitors.

Authors:  Raphael Reher; Allegra T Aron; Pavla Fajtová; Paolo Stincone; Berenike Wagner; Alicia I Pérez-Lorente; Chenxi Liu; Ido Y Ben Shalom; Wout Bittremieux; Mingxun Wang; Kyowon Jeong; Marie L Matos-Hernandez; Kelsey L Alexander; Eduardo J Caro-Diaz; C Benjamin Naman; J H William Scanlan; Phil M M Hochban; Wibke E Diederich; Carlos Molina-Santiago; Diego Romero; Khaled A Selim; Peter Sass; Heike Brötz-Oesterhelt; Chambers C Hughes; Pieter C Dorrestein; Anthony J O'Donoghue; William H Gerwick; Daniel Petras
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

7.  Insight into Unprecedented Diversity of Cyanopeptides in Eutrophic Ponds Using an MS/MS Networking Approach.

Authors:  Andreja Kust; Klára Řeháková; Jaroslav Vrba; Vincent Maicher; Jan Mareš; Pavel Hrouzek; Maria-Cecilia Chiriac; Zdeňka Benedová; Blanka Tesařová; Kumar Saurav
Journal:  Toxins (Basel)       Date:  2020-08-31       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.